Evaluation of Dose-Adjusted EPOCH-R Compared with R-CHOP for the Treatment of High-Risk, Aggressive B-Cell Lymphomas: A Single-Center Experience

被引：1
|
作者：
Rockwell, Sarah J.
Richter, Katherine A.
Caddell, Ryan J.
Chavez, Julio C.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140085
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Real-World Outcome of Dose-Adjusted EPOCH-R, a Single-Centre Experience
    Wong, Rachel
    Kansara, Roopesh R.
    BLOOD, 2020, 136
  • [22] Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study
    Rutherford, Sarah C.
    Abramson, Jeremy S.
    Bartlett, Nancy L.
    Barta, Stefan K.
    Khan, Nadia
    Joyce, Robin
    Maddocks, Kami
    Ali-Shaw, Trisha
    Senese, Silvia
    Yuan, Ying
    Westin, Jason
    Leonard, John P.
    LANCET HAEMATOLOGY, 2021, 8 (11): : E818 - E827
  • [23] R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis
    Shah, Nirav N.
    Szabo, Aniko
    Huntington, Scott F.
    Epperla, Narendranath
    Reddy, Nishitha
    Ganguly, Siddhartha
    Vose, Julie
    Obiozor, Cynthia
    Faruqi, Fahad
    Kovach, Alexandra E.
    Costa, Luciano J.
    Xaiver, Ana C.
    Okal, Ryan
    Kanate, Abraham S.
    Ghosh, Nilanjan
    Kharfan-Dabaja, Mohamed A.
    Strelec, Lauren
    Hamadani, Mehdi
    Fenske, Timothy S.
    Calzada, Oscar
    Cohen, Jonathon B.
    Chavez, Julio
    Svoboda, Jakub
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (04) : 534 - 544
  • [24] Is Dose-Adjusted EPOCH-R Less Effective in Children Than Adults With Primary Mediastinal B-Cell Lymphoma?
    Lakhotia, Rahul
    Melani, Christopher
    Roschewski, Mark
    Wilson, Wyndham H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (18) : 2063 - +
  • [25] Immunochemotherapy (R-CHOP, R-EPOCH) in the treatment of diffuse B-cell large cell lymphomas (DLCL) - A single institution expirience
    Mihaljevic, B
    Nedeljkov-Jancic, R
    Jankovic, S
    Cemerikic, V
    Petrovic, M
    Boskovic, D
    ANNALS OF ONCOLOGY, 2005, 16 : 178 - 178
  • [26] Multi-center study of dose-adjusted epoch-R in untreated diffuse large B-cell lymphoma-CALGB50103
    Wilson, W. H.
    Zelenetz, A. D.
    Niedzwiecki, D.
    Hurd, D.
    Martin, S. E.
    Czuczman, M.
    Johnson, J. L.
    Canellos, G. P.
    Cheson, B. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 146 - 147
  • [27] Dose-adjusted R-EPOCH for the treatment of primary mediastinal B-cell lymphoma: the West Anglia experience
    Grigoropoulos, N. F.
    Nagumantree, S.
    Hodson, A.
    Cooke, L.
    Karanth, M.
    Cheow, H. K.
    Shaw, A. S.
    Crawley, C. R.
    Bulusu, R.
    Williams, M. V.
    Follows, G. A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 : 55 - 56
  • [28] Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement
    Kojima, Minoru
    Amaki, Jun
    Ogiya, Daisuke
    Ando, Kiyoshi
    Nakamura, Naoya
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2020, 60 (02) : 60 - 61
  • [29] Treatment of high risk aggressive B cell lymphomas with DA EPOCH R- a single center retrospective analysis
    Panny, M.
    Keil, F.
    Moestl, M.
    Kornberger, T.
    Menschel, E.
    Simanek, R.
    Noesslinger, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 : 67 - 68
  • [30] DOSE-ADJUSTED EPOCH PLUS RITUXIMAB (DA-EPOCH-R) REDUCES THE RISK OF CNS RELAPSE IN PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A SINGLE CENTRE EXPERIENCE
    Garcia-Suarez, J.
    De Miguel, D.
    Martin, Y.
    Gil-Fernandez, J. J.
    Pascual, T.
    Magro, H.
    Lopez-Rubio, M.
    Burgaleta, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 438 - 438
12345